The results indicated that RIPK2 expression was significantly linked to MSI in 33 different cancer types, with negative correlations observed in DLBC and KIPAN, and positive correlations observed in BRCA, BLCA, STAD, UCEC, THYM, STES, and SARC (Supplementary Figure 1A). This evidence concerns the gene RIPK2 and cancer.